Using ear stimulation to treat chronic pain and opioid withdrawal
Official title: Understanding the Mechanistic, Neurophysiological, and Antinociceptive Effects of Transcutaneous Auricular Neurostimulation for Treatment of Chronic Pain
Run by The University of Texas Medical Branch, Galveston · NCT05555485 · Data updated 2026-11-12
This study is testing whether a device that stimulates nerves around the ear can help people with chronic pain and those going through opioid withdrawal feel better.
Quick facts
| Study type | Interventional |
|---|---|
| Ages | 18 Years to 65 Years |
| Sex | All |
| Enrollment | 60 (estimated) |
| Sponsor | The University of Texas Medical Branch, Galveston Academic / other |
| Locations | 1 site (Galveston, Texas) |
| Status | Recruiting |
| Started | May 24, 2023 |
| Main results expected | July 21, 2027 |
| Study ends | September 30, 2027 |
| Registry record updated | August 10, 2026 |
| Trial ID | NCT05555485 on ClinicalTrials.gov |
Is this trial a fit for you?
✓Likely a good fit
Ideal candidates are adults aged 18 to 65 who experience chronic pain and are willing to taper their opioid medication.
✕Probably not a fit
Patients currently undergoing cancer treatment or with a history of seizures may not benefit from this study.
A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.
What this trial studies
This study investigates the effects of a device that stimulates nerves around the ear to alleviate chronic pain and symptoms of opioid withdrawal. Participants will reduce their opioid medication while receiving either active or sham stimulation over a two-day period in a clinical research center. The study aims to establish a neurophysiological signature of how this stimulation affects pain perception and withdrawal symptoms using functional MRI. Participants will complete questionnaires to assess their pain levels before and after the treatment.
Why it matters
Potential benefit: If successful, this approach could provide a non-pharmacological method to manage chronic pain and ease opioid withdrawal symptoms.
How similar studies have gone: Previous studies on transcutaneous auricular neurostimulation have shown promise in managing pain and withdrawal symptoms, suggesting potential success for this approach.
Who can join: the full rules
Show full inclusion / exclusion criteria
Inclusion Criteria: * Males and females between 18 and 65 years of age * Participant is able to provide informed consent and function at an intellectual level sufficient for study requirements * Presence of pain on more than half of the days in the last six months * Must have proof of prescribed medication by either showing a prescription bottle with the individual's name or the presence of a prescription on the Prescription Drug Monitoring Program (PDMP) * Willingness to taper opioid dose by at least 10% * Patient or provider requests opioid dose reduction or discontinuation. * Urine Drug Screen (UDS) must be positive for their prescribed opioid * Urine Drug Test must be negative for illicit drugs, benzodiazepines, and nonprescribed opioids * Must agree to use nicotine patches and/or gum instead of smoking or vaping in the UTMB facilities Exclusion Criteria: * Currently receiving treatment for cancer * Participant has a history of epileptic seizures * Participant has a history of neurological diseases or traumatic brain injury * Participant has abnormal ear anatomy or current ear infection present * Participant has presence of devices, e.g., pacemakers, cochlear prosthesis, neurostimulators * Currently receiving a prescription benzodiazepine medication * Current prescription opioid dose \>50 MME/day * Current abuse of illicit drugs or alcohol (nicotine use is acceptable). * Surgery within the previous month * Report of suicide attempt or psychiatric hospitalization in the past 10 years. * Current suicidal ideation with specific plan or intent * Women of childbearing potential not using adequate contraception as per investigator judgment or not willing to comply with contraception for the duration of the study * Females who are pregnant or lactating * Participant has any other significant disease or disorder which, in the opinion of the Investigator, may either put the participants at risk because of participation in the trial, or may influence the result of the trial, or the participant's ability to participate in the trial
Where it's running
-
University of Texas Medical Branch
Galveston, Texas, United States Recruiting
Similar studies
Other studies for the same condition or treatment. Recruiting studies are listed first.
-
Anterior Knee Nerves Block vs Femoral Nerve Block for Knee Arthroscopy
This trial tests whether an anterior nerves of the knee (ANK) block provides similar pain relief to a femoral nerve block after knee arthroscopy in adults, aiming to reduce quadriceps weakness.
-
Esmolol vs Dexmedetomidine for opioid-sparing in laparoscopic gynecologic surgery
This study tests whether low-dose esmolol or dexmedetomidine, given during surgery, reduces opioid use and improves pain control after laparoscopic hysterectomy compared with placebo.
-
Three nerve blocks for knee replacement: which one works best
This trial tests three different nerve blocks used during knee replacement to see which provides the best pain relief for patients after surgery.
-
Rectointercostal plane block to reduce pain after laparoscopic gallbladder removal
This study tests whether giving a rectointercostal block during laparoscopic cholecystectomy can lower postoperative pain for patients without changing general anesthesia.
-
STIL block versus RIB with sub-serratus plane block for pain relief after pediatric chest surgery
This study tests whether the STIL plane block provides comparable or better pain relief than the combination of RIB and sub-serratus plane block in children after thoracotomy.
-
SPSIP Block to Help Pain After Breast Reduction Surgery
A randomized trial tests whether adding an ultrasound-guided SPSIP block can lower opioid use in the first 24 hours after bilateral breast reduction surgery.
How to take part
- Review the eligibility criteria above with your treating physician.
- Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
- Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.